Stanislav Gobec

9.4k total citations · 1 hit paper
298 papers, 7.6k citations indexed

About

Stanislav Gobec is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Stanislav Gobec has authored 298 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Molecular Biology, 111 papers in Organic Chemistry and 76 papers in Pharmacology. Recurrent topics in Stanislav Gobec's work include Computational Drug Discovery Methods (56 papers), Cholinesterase and Neurodegenerative Diseases (51 papers) and Chemical Synthesis and Analysis (42 papers). Stanislav Gobec is often cited by papers focused on Computational Drug Discovery Methods (56 papers), Cholinesterase and Neurodegenerative Diseases (51 papers) and Chemical Synthesis and Analysis (42 papers). Stanislav Gobec collaborates with scholars based in Slovenia, France and United Kingdom. Stanislav Gobec's co-authors include Didier Blanot, Matej Sova, Izidor Sosič, Andreja Kovač, Samo Turk, Damijan Knez, Janko Kos, Tea Lanišnik Rižner, Hélène Barreteau and Audrey Boniface and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Stanislav Gobec

288 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytoplasmic steps of peptidoglycan biosynthesis

2008 545 citations Hélène Barreteau, Andreja Kovač et al. FEMS Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stanislav Gobec Slovenia	46	3.6k	2.7k	1.7k	1.5k	912	298	7.6k
Jonathan B. Baell Australia	39	5.1k 1.4×	2.5k 0.9×	929 0.5×	2.2k 1.5×	257 0.3×	177	9.2k
Christian Oefner Switzerland	31	3.5k 1.0×	1.1k 0.4×	1.9k 1.1×	1.2k 0.8×	466 0.5×	39	6.0k
Leah L. Frye United States	18	7.1k 2.0×	2.9k 1.1×	1.4k 0.8×	3.8k 2.6×	391 0.4×	32	11.8k
Yves Bourne France	48	5.4k 1.5×	1.8k 0.7×	1.5k 0.9×	993 0.7×	453 0.5×	115	8.0k
Gerhard Wolber Germany	42	4.5k 1.2×	1.8k 0.7×	1.1k 0.6×	2.7k 1.8×	308 0.3×	218	8.0k
Rolf W. Hartmann Germany	55	4.2k 1.2×	2.9k 1.1×	909 0.5×	826 0.6×	3.1k 3.4×	377	10.0k
Giuseppe Bifulco Italy	50	3.9k 1.1×	3.3k 1.2×	1.8k 1.0×	586 0.4×	351 0.4×	277	8.7k
Jasna Klicić United States	6	4.9k 1.4×	1.9k 0.7×	954 0.6×	3.0k 2.0×	280 0.3×	8	7.9k
Ronald J. Quinn Australia	51	5.1k 1.4×	3.7k 1.4×	3.2k 1.8×	859 0.6×	280 0.3×	326	11.5k
Sylvie Garneau‐Tsodikova United States	45	4.5k 1.2×	2.3k 0.8×	1.9k 1.1×	249 0.2×	367 0.4×	174	8.0k

Countries citing papers authored by Stanislav Gobec

Since Specialization

Citations

This map shows the geographic impact of Stanislav Gobec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislav Gobec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislav Gobec more than expected).

Fields of papers citing papers by Stanislav Gobec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanislav Gobec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislav Gobec. The network helps show where Stanislav Gobec may publish in the future.

Co-authorship network of co-authors of Stanislav Gobec

This figure shows the co-authorship network connecting the top 25 collaborators of Stanislav Gobec. A scholar is included among the top collaborators of Stanislav Gobec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanislav Gobec. Stanislav Gobec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Švajger, Urban, Ana Mitrović, Borut Prestor, et al.. (2025). Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models. Frontiers in Immunology. 16. 1708281–1708281.

Pajk, Stane, et al.. (2025). α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity. Journal of Medicinal Chemistry. 68(24). 26405–26417.

Wasowski, Cristina, et al.. (2024). 3,3-Dibromoflavanone, a synthetic flavonoid derivative for pain management with antidepressant-like effects and fewer side effects than those of morphine in mice. Chemico-Biological Interactions. 402. 111189–111189. 1 indexed citations

Švajger, Urban, et al.. (2024). Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists. ACS Omega. 9(2). 2362–2382. 2 indexed citations

Rejc, Luka, Damijan Knez, Alba Espargaró, et al.. (2024). Probing Alzheimer's pathology: Exploring the next generation of FDDNP analogues for amyloid β detection. Biomedicine & Pharmacotherapy. 175. 116616–116616.

Bautista‐Aguilera, Óscar M., José M. Alonso, Marco Catto, et al.. (2022). N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases. Molecules. 27(21). 7437–7437. 6 indexed citations

Knez, Damijan, Izidor Sosič, Janez Mravljak, et al.. (2022). Repurposing of 8‐Hydroxyquinoline‐Based Butyrylcholinesterase and Cathepsin B Ligands as Potent Nonpeptidic Deoxyribonuclease I Inhibitors. ChemMedChem. 17(5). e202100694–e202100694. 6 indexed citations

Pirc, Katja, Vesna Hodnik, Tea Lenarčič, et al.. (2021). Nep1-like proteins as a target for plant pathogen control. PLoS Pathogens. 17(4). e1009477–e1009477. 16 indexed citations

Knez, Damijan, et al.. (2021). 2’-Hydroxy-4’,5’-dimethyl-4-dimethylaminochalcone, a novel fluorescent flavonoid with capacity to detect aluminium in cells and modulate Alzheimer’s disease targets. Journal of Photochemistry and Photobiology A Chemistry. 409. 113137–113137. 15 indexed citations

10.

Wichur, Tomasz, Anna Pasieka, Justyna Godyń, et al.. (2021). Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau. European Journal of Medicinal Chemistry. 225. 113783–113783. 21 indexed citations

11.

Knez, Damijan, Diego B. Carvalho, Simon Žakelj, et al.. (2021). Multitarget 2′-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities. Neuropharmacology. 201. 108837–108837. 9 indexed citations

12.

Gobec, Stanislav, et al.. (2021). Synthesis of 3-Amino-4-substituted Monocyclic ß-Lactams—Important Structural Motifs in Medicinal Chemistry. International Journal of Molecular Sciences. 23(1). 360–360. 5 indexed citations

13.

Sosič, Izidor, et al.. (2019). A focused structure–activity relationship study of psoralen-based immunoproteasome inhibitors. MedChemComm. 10(11). 1958–1965. 10 indexed citations

14.

Panek, Dawid, Anna Więckowska, Anna Pasieka, et al.. (2018). Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents. Molecules. 23(2). 347–347. 35 indexed citations

15.

Więckowska, Anna, Tomasz Wichur, Justyna Godyń, et al.. (2018). Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease. ACS Chemical Neuroscience. 9(5). 1195–1214. 44 indexed citations

16.

Panek, Dawid, Anna Więckowska, Jakub Jończyk, et al.. (2018). Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents. ACS Chemical Neuroscience. 9(5). 1074–1094. 49 indexed citations

17.

Batson, Sarah, Cesira de Chiara, Adrian J. Lloyd, et al.. (2017). Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine. Nature Communications. 8(1). 1939–1939. 65 indexed citations

18.

Bajda, Marek, Anna Więckowska, Anna Pasieka, et al.. (2016). Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta. Molecules. 21(4). 410–410. 29 indexed citations

19.

Lešnik, Samo, Mitja M. Zdouc, An Ghysels, et al.. (2016). Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction. Journal of Medicinal Chemistry. 59(24). 11069–11078. 27 indexed citations

20.

Barreteau, Hélène, Andreja Kovač, Audrey Boniface, et al.. (2008). Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiology Reviews. 32(2). 168–207. 545 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact